Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

420
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
420
Clinical Trials01:16

Clinical Trials

10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Leveling Effect01:29

Leveling Effect

1.4K
In acid-base chemistry, the leveling effect refers to the limitation imposed by the solvent on the strength of acids and bases in solution. When a base stronger than the solvent's conjugate base is used, it deprotonates the solvent until the base is entirely consumed, making it ineffective against weaker acids. Conversely, an acid stronger than the solvent's conjugate acid protonates the solvent until the acid is depleted, rendering it ineffective against weaker bases. Essentially, the...
1.4K
Optimal Foraging00:48

Optimal Foraging

13.8K
How animals obtain and eat their food is called foraging behavior. Foraging can include searching for plants and hunting for prey and depends on the species and environment.
13.8K
High-Level and Low-Level Awareness01:19

High-Level and Low-Level Awareness

757
Controlled processes in human consciousness represent high-alert mental states where individuals deliberately focus their attention on achieving specific goals. Controlled processes can be seen in situations like mastering new technology, where a person might become so absorbed that they ignore surrounding distractions. Such processes involve selective attention, requiring one to concentrate on particular elements of experience while disregarding others. These are governed by executive...
757

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A sensitivity analysis approach to principal stratification with a continuous longitudinal intermediate outcome: applications to a cohort stepped wedge trial.

Biostatistics (Oxford, England)·2026
Same author

Evaluation of clinical utility in emulated clinical trials.

European journal of epidemiology·2026
Same author

Long-term memory effects of an incremental blood pressure intervention in a mortal cohort.

Biometrics·2026
Same author

Bayesian feature selection in joint models with application to a cardiovascular disease cohort study.

Statistical methods in medical research·2026
Same author

A Bayesian semi-parametric approach to causal mediation for longitudinal mediators and time-to-event outcomes with application to a cardiovascular disease cohort study.

Biostatistics (Oxford, England)·2025
Same author

Re: ratios in regression analyses with causal questions.

American journal of epidemiology·2025
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

818

Optimizing and evaluating biomarker combinations as trial-level general surrogates.

Erin E Gabriel1, Michael C Sachs2, Michael J Daniels3

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Statistics in Medicine
|October 12, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for evaluating combinations of biomarkers as general surrogates in clinical trials. The research identifies the optimal biomarker subset for rotavirus vaccine efficacy, confirming previous findings.

Keywords:
causal inferencenonparametric Bayesianpredictionrotavirussurrogacy

More Related Videos

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

11.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K

Related Experiment Videos

Last Updated: Feb 4, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

818
Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

11.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Biomarker Discovery

Background:

  • General surrogate endpoints are crucial for efficient clinical trial evaluation.
  • Existing methods for surrogate evaluation often focus on single biomarkers.
  • Evaluating combinations of biomarkers presents a complex challenge in trial-level surrogate analysis.

Purpose of the Study:

  • To extend existing methods for trial-level general surrogate evaluation to include combinations of biomarkers.
  • To develop a procedure for identifying the optimal combination of biomarkers based on prediction error.
  • To apply the developed method to evaluate biomarkers for the pentavalent rotavirus vaccine (RV5).

Main Methods:

  • Utilized a nonparametric Bayesian model for flexible surrogate evaluation.
  • Developed a procedure to select optimal biomarker subsets, reducing model specification complexity.
  • Employed simulations to assess the operating characteristics of the proposed method.
  • Applied the method to real-world data for rotavirus vaccine (RV5) surrogates.

Main Results:

  • The proposed method effectively evaluates combinations of biomarkers as trial-level general surrogates.
  • The nonparametric Bayesian model successfully identified an optimal subset of biomarkers.
  • Simulations demonstrated the method's robustness and efficiency.
  • Analysis of rotavirus vaccine (RV5) data confirmed a previously identified single biomarker as the optimal surrogate.

Conclusions:

  • The developed method offers a robust approach for selecting optimal biomarker combinations for trial-level general surrogates.
  • This advancement facilitates more efficient and accurate clinical trial evaluations.
  • The findings reinforce the utility of the identified single biomarker for rotavirus vaccine (RV5) surrogate evaluation.